Literature DB >> 7461504

Antithrombin III versus prothrombin in liver cirrhosis.

M H Aurousseau, J L d'Angeli, F Josso.   

Abstract

In patients with liver cirrhosis, a close relationship was observed between the respective levels of antithrombin III and prothrombin, both below 50% in 20 our 27 patients. The absence of any thrombotic complication, despite low plasma antithrombin III, suggests that the preserved balance between the inhibitor and the zymogens of the inhibited enzymes could have a protective effect against thrombotic tendency.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7461504     DOI: 10.1159/000214393

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  2 in total

1.  Hepatocarcinoma in cirrhosis. Is antithrombin III a neoplastic marker?

Authors:  A Grieco; V De Stefano; A Cassano; A Ciabattoni; C Garufi; A Astone; G Leone; C Barone
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.

Authors:  J J Rodzynek; D Urbain; P Leautaud; P Wettendorff; A Delcourt
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.